Evolution and transmission of drug-resistant tuberculosis in a Russian population

Nicola Casali, Vladyslav Nikolayevskyy, Yanina Balabanova, Simon R Harris, Olga Ignatyeva, Irina Kontsevaya, Jukka Corander, Josephine Bryant, Julian Parkhill, Sergey Nejentsev, Rolf D Horstmann, Timothy Brown, Francis Drobniewski

Research output: Contribution to journalArticleAcademicpeer-review

376 Citations (Scopus)

Abstract

The molecular mechanisms determining the transmissibility and prevalence of drug-resistant tuberculosis in a population were investigated through whole-genome sequencing of 1,000 prospectively obtained patient isolates from Russia. Two-thirds belonged to the Beijing lineage, which was dominated by two homogeneous clades. Multidrug-resistant (MDR) genotypes were found in 48% of isolates overall and in 87% of the major clades. The most common rpoB mutation was associated with fitness-compensatory mutations in rpoA or rpoC, and a new intragenic compensatory substitution was identified. The proportion of MDR cases with extensively drug-resistant (XDR) tuberculosis was 16% overall, with 65% of MDR isolates harboring eis mutations, selected by kanamycin therapy, which may drive the expansion of strains with enhanced virulence. The combination of drug resistance and compensatory mutations displayed by the major clades confers clinical resistance without compromising fitness and transmissibility, showing that, in addition to weaknesses in the tuberculosis control program, biological factors drive the persistence and spread of MDR and XDR tuberculosis in Russia and beyond.

Original languageEnglish
Pages (from-to)279-86
Number of pages8
JournalNature Genetics
Volume46
Issue number3
DOIs
Publication statusPublished - Mar 2014
Externally publishedYes

Keywords

  • Bacterial Proteins/genetics
  • DNA-Directed RNA Polymerases
  • Drug Resistance, Multiple, Bacterial/genetics
  • Evolution, Molecular
  • Extensively Drug-Resistant Tuberculosis/epidemiology
  • Genes, Bacterial
  • Humans
  • Mutation
  • Mycobacterium tuberculosis/drug effects
  • Phylogeny
  • Polymorphism, Single Nucleotide
  • Prevalence
  • Prospective Studies
  • Russia/epidemiology
  • Tuberculosis, Multidrug-Resistant/epidemiology
  • Virulence/genetics

Cite this